Watchlist Price Alert

Bone Biologics Corporatio... (BBLG)

NASDAQ: BBLG · Real-Time Price · USD

4.93

0.16 (3.37%)

At close: Jun 16, 2025, 3:59 PM

4.81

-2.43%

Pre-market: Jun 17, 2025, 07:00 AM EDT

Bone Biologics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	50.00	96.00	96.00	700.00
Gross Profit	n/a	n/a	n/a	n/a	n/a	-50	-96	-96	-700
Operating Income	-4.22M	-9.43M	-3.67M	-1.1M	-825K	-2.45M	-2.79M	-2.63M	-17.85M
Interest Income	55.66K	1.87K	731.71	805.11	998.08	n/a	n/a	n/a	n/a
Pretax Income	-7.33M	-8.95M	-1.49M	-1.61M	-1.82M	-3.42M	-4.43M	-7.05M	-21.03M
Net Income	-4.11M	-8.95M	-1.49M	-1.61M	-1.82M	-3.42M	-4.43M	-7.05M	-25.88M
Selling & General & Admin	2.09M	2.52M	2.09M	1.02M	484.34K	1.35M	2.69M	3.82M	6.25M
Research & Development	2.13M	6.91M	1.58M	82.04K	340.67K	1.1M	104.49K	1.33M	11.6M
Other Expenses	n/a	n/a	n/a	n/a	n/a	-0.00	104.49K	-2.66M	n/a
Operating Expenses	4.22M	9.43M	3.67M	1.1M	825.01K	2.45M	2.79M	2.63M	17.85M
Interest Expense	n/a	n/a	n/a	805.11K	998.08K	975.77K	1.23M	4.42M	3.17M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	4.22M	9.43M	3.67M	1.1M	825.01K	2.45M	2.79M	2.63M	17.85M
Income Tax Expense	n/a	n/a	-2.18M	1.6K	1.6K	1.6K	1.73K	1.6K	2.24K
Shares Outstanding (Basic)	1.52M	263.14K	47.6K	43K	51K	51K	n/a	n/a	n/a
Shares Outstanding (Diluted)	1.52M	263.14K	47.66K	43.13K	51.14K	51.14K	n/a	n/a	n/a
EPS (Basic)	-4.83	-34.01	-31.15	-37.35	-35.68	-66.97	n/a	n/a	n/a
EPS (Diluted)	-4.83	-34.01	-31.2	-84	-151.2	-66.97	n/a	n/a	n/a
EBITDA	-4.11M	479.57K	-4.4M	-1.1M	-825K	-2.45M	-2.79M	-2.63M	-20.41M
EBIT	-4.11M	-8.95M	-3.67M	-1.1M	-825K	-2.45M	-2.79M	-2.63M	-20.41M
Depreciation & Amortization	4.22M	9.43M	3.67M	1.1M	50.00	50.00	96.00	96.00	700.00